U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Protein
Created
by admin
on Tue Apr 01 21:17:31 GMT 2025
Edited
by admin
on Tue Apr 01 21:17:31 GMT 2025
Protein Type MONOCLONAL ANTIBODY CONJUGATE
Protein Sub Type IGG1|KAPPA
Sequence Origin HUMANIZED MOUSE
Sequence Type COMPLETE
Record UNII
37DMF82G1F
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Trastuzumab Envedotin
INN  
Official Name English
DP-303C
Preferred Name English
immunoglobulin G1-kappa, anti-[Homo sapiens ERBB2 (receptor tyrosine-protein kinase erbB-2, epidermal growth factor receptor 2, EGFR2, HER2, HER-2, p185c-erbB2, NEU, CD340)], humanized monoclonal antibody, conjugated at glutaminyl residues to monomethyla
Common Name English
Immunoglobulin G1, anti-(human epidermal growth factor receptor HER2) (human-Mus musculus monoclonal DP001 ?1-chain), disulfide with human-Mus musculus monoclonal DP001 ?-chain, dimer, 298,298?-diamide with N-[[[4-[[N-[2-[2-[2-(2-aminoethoxy)ethoxy]ethox
Common Name English
trastuzumab envedotin [INN]
Common Name English
H-gamma1 heavy chain humanized (1-450) [VH (Homo sapiens IGHV3-66*01 (81.6%) -(IGHD) -IGHJ4*01 (100%), CDR-IMGT [8.8.13] (26-33.51-58.97-109)) (1-120) -Homo sapiens IGHG1*03v, G1m3>G1m17, nG1m1 CH1 K120, CH3 E12, M14 (CH1 R120>K (217) (121-218), hinge 1-
Common Name English
DP303C
Code English
Code System Code Type Description
SMS_ID
300000054738
Created by admin on Tue Apr 01 21:17:31 GMT 2025 , Edited by admin on Tue Apr 01 21:17:31 GMT 2025
PRIMARY
FDA UNII
37DMF82G1F
Created by admin on Tue Apr 01 21:17:31 GMT 2025 , Edited by admin on Tue Apr 01 21:17:31 GMT 2025
PRIMARY
NCI_THESAURUS
C173962
Created by admin on Tue Apr 01 21:17:31 GMT 2025 , Edited by admin on Tue Apr 01 21:17:31 GMT 2025
PRIMARY
CAS
2865132-89-2
Created by admin on Tue Apr 01 21:17:31 GMT 2025 , Edited by admin on Tue Apr 01 21:17:31 GMT 2025
PRIMARY
INN
13009
Created by admin on Tue Apr 01 21:17:31 GMT 2025 , Edited by admin on Tue Apr 01 21:17:31 GMT 2025
PRIMARY
From To
4_134 4_194
4_23 4_88
3_134 3_194
3_23 3_88
2_223 4_214
2_147 2_203
2_22 2_96
1_223 3_214
1_147 1_203
1_22 1_96
1_229 2_229
1_232 2_232
1_264 1_324
2_264 2_324
1_370 1_428
2_370 2_428
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_300
N 2_300
Related Record Type Details
PARENT -> CONJUGATE
TARGET->CONJUGATED TOXIN

Structural Modifications

Modification Type Location Site Location Type Residue Modified Extent Fragment Name Fragment Approval
AMINO_ACID_SUBSTITUTION [1_298] [2_298] SITE_SPECIFIC Q UNSPECIFIED SUBSTANCE
ae55cece
(not in database)
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL